| 1/4 | US=102 / Tese/FAP Vidal DO. Avaliação da freqüência de metilação de promotores nas síndromes mielodisplásicas da infância. São Paulo, 2005. 74 p. Dissertação(Mestrado)-Fundação Antonio Prudente. Disponível em: http://accamargo.phlnet.com.br/MESTRADO/2005/DanielOnofreVidal/DanielOnofreVidalmestrado.pdf SINDROMES MIELODISPLASICAS. GENETICA; MEDULA OSSEA; METILACAO DE DNA; CRIANCA |
| 2/4 | US=84-A / Biol/Mol Wilkinson DS, Barton MC. Transformig growth factor-B in developing and advanced cancers: tumor suppressors p53 and TGFB converge to regulate the alpha-fetoprotein oncodevelopmental tumor marker. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 309-20. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. |
| 3/4 | US=84-A / Biol/Mol Wilkinson DS, Barton MC. Transformig growth factor-B in developing and advanced cancers: tumor suppressors p53 and TGFB converge to regulate the alpha-fetoprotein oncodevelopmental tumor marker. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 309-20. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. |
| 4/4 | US=2 / Biol/Mol Ramadan S, Sayan E, Oberst A, Chikh A, Pietroni V, Rufini A, Melino G, Bernassola F. Oncogenes/tumor suppressor genes: p73 affects cell fate and tumorigenesis. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 536-50. ISBN 978-3-527-31237-5. |
